Role of prebiotics and probiotics in pediatric diseases

Sabrina Cardile1, Tommaso Alterio, Teresa Arrigo

  • 1Department of Pediatric Sciences, University of Messina, Messina, Italy - t.alterio@gmail.com.

Minerva Pediatrica
|May 1, 2015
PubMed

Insights

Probiotics and prebiotics modulate gut flora, offering benefits but requiring cautious use, especially in immunocompromised individuals. Further research is needed to define optimal applications and dosages for various conditions.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Human Health

Background:

  • Growing understanding of gut microflora's role in human health.
  • Increased use of probiotics and prebiotics for gut flora modulation.
  • Concerns regarding indiscriminate use and safety in specific populations.

Purpose of the Study:

  • To review the current applications and safety considerations of probiotics and prebiotics.
  • To highlight evidence-based uses and areas needing further research.
  • To emphasize prudent usage, particularly in vulnerable patient groups.

Main Methods:

  • Literature review on the efficacy and safety of probiotics and prebiotics.
  • Analysis of current clinical evidence for various health conditions.
  • Assessment of risks associated with probiotic use in specific patient populations.

Main Results:

  • Probiotics and prebiotics demonstrate benefits in certain conditions like viral gastroenteritis and antibiotic-associated diarrhea in children.
  • Evidence supports their use in pouchitis and mild ulcerative colitis.
  • Indiscriminate use is noted, with significant risks in immunocompromised patients, including sepsis.

Conclusions:

  • Probiotic and prebiotic use is beneficial but requires careful consideration of strain specificity and patient condition.
  • Prudent application is essential, especially for immunocompromised individuals and those with severe chronic diseases.
  • Further studies are required to establish optimal dosages and treatment durations for various clinical indications.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
231
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
44
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
41